Additionally, CCL2 overexpression enhances cancer cell migration and recruits immunosuppressive cells to the tumor microenvironment, creating conditions that support tumor progression, and its elevated expression is associated with a poor prognosis in GBM patients [34]. Here, CCL2 is linked to glioblastoma.